Day Lucy 4
4 · AN2 Therapeutics, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Day Lucy
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-01-03$1.34/sh−2,957$3,965→ 32,670 total
Footnotes (3)
- [F1]Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on January 1, 2025.
- [F2]Includes 20,625 RSUs which vest as follows: 1/3rd of the RSUs vest annually over three years from January 1, 2025, subject to the Reporting Person continuing to provide services to the Company as an employee, consultant or director of the Company through each applicable vesting date.
- [F3]Includes 5,000 shares purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from reporting under Section 16(b)3.